FDA Drug Application (201503) for CABERGOLINE by APOTEX CORP

Back to FDA Applications sponsored by APOTEX CORP

Application Number201503
Product Number001
FormTABLET;ORAL
Dosage0.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCABERGOLINE
Active IngredientCABERGOLINE



Back to FDA Applications sponsored by APOTEX CORP

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.